BCAB – bioatla, inc. (US:NASDAQ)
Stock Stats
News
BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing
BioAtla Inc (BCAB) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Promising Trial ... [Yahoo! Finance]
BioAtla outlines $800M peak sales target for Oz-V as FDA alignment paves way for phase III launch [Seeking Alpha]
BioAtla, Inc. (BCAB) Q3 2025 Earnings Call Transcript [Seeking Alpha]
BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas
Form DEF 14A BioAtla, Inc. For: Dec 05
Form 4 BioAtla, Inc. For: Nov 30 Filed by: WALDRON RICHARD A
Form 4 BioAtla, Inc. For: Nov 30 Filed by: SHORT JAY M PHD
Form 4 BioAtla, Inc. For: Nov 30 Filed by: Vasquez Christian
Form 4 BioAtla, Inc. For: Nov 30 Filed by: Sievers Eric
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.